Clinical Cancer Research: Characterization of Fibroblast Growth Factor Receptor Alterations and Activation in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

News & Events

Clinical Cancer Research: Characterization of Fibroblast Growth Factor Receptor Alterations and Activation in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Date Published:
Date of Event:

Study utilized GeneCentric’s RNA-based FGFR Predictive Response Signature (FGFR-PRS) and showed it could identify twice as many patients with an activated FGFR pathway compared to patients with FGFR DNA alteration biomarkers

Link: Clinical Cancer Research